Cargando…
Integrated Analysis to Obtain Potential Prognostic Signature in Glioblastoma
Glioblastoma multiforme (GBM) is the most malignant and multiple tumors of the central nervous system. The survival rate for GBM patients is less than 15 months. We aimed to uncover the potential mechanism of GBM in tumor microenvironment and provide several candidate biomarkers for GBM prognosis. I...
Autores principales: | Chen, Jia-Qi, Zhang, Nuo, Su, Zhi-Lin, Qiu, Hui-Guo, Zhuang, Xin-Guo, Tao, Zhi-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766324/ https://www.ncbi.nlm.nih.gov/pubmed/35069135 http://dx.doi.org/10.3389/fnint.2021.717629 |
Ejemplares similares
-
An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
por: Yang, Yang, et al.
Publicado: (2021) -
Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma
por: Zhang, Ao, et al.
Publicado: (2023) -
Construction of co‐expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma
por: Zhou, Jing, et al.
Publicado: (2021) -
Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme
por: Wang, Jinghua, et al.
Publicado: (2022) -
A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients
por: Hou, Ziming, et al.
Publicado: (2019)